Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Masocco, Maria ^a   Kodra, Yllka ^a   Vichi, Monica ^a   Conti, Susanna ^a   Kanieff, Mark ^a   Pace, Monica ^b   Frova, Luisa ^b   Taruscio, Domenica ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ARTICLE; BRAIN CANCER; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC BRONCHITIS; CONGENITAL DISORDER; DEATH CERTIFICATE; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASE; EVALUATION; FEMALE; GENDER; GERIATRIC PATIENT; HUMAN; HYPERTENSION; INFECTION; INJURY; INTOXICATION; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; MUSCULOSKELETAL DISEASE; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; POPULATION RESEARCH; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SOFT TISSUE CANCER; UROGENITAL TRACT DISEASE; NONPARAMETRIC TEST; RETROSPECTIVE STUDY;

AGE FACTORS; CAUSE OF DEATH; DEATH CERTIFICATES; FEMALE; HUMANS; ITALY; MALE; NEUROFIBROMATOSIS 1; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 79953126283     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-11     Document Type: Article

References (39)

1. Epidemiology of neurofibromatosis type 1. JM Friedman, Am J Med Genet 1999 89 1 6 10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8 10469430 (Pubitemid 30033170)
2. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. SM Huson DA Compston P Clark PS Harper, J Med Genet 1989 26 704 11 10.1136/jmg.26.11.704 2511318 (Pubitemid 19270599)
3. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. NIH, Arch Neurol 1988 45 575 78 3128965
4. On the natural history of von Recklinghausen neurofibromatosis. SA Sørensen JJ Mulvihill A Nielsen, Ann N Y Acad Sci 1986 486 30 7 3105394 (Pubitemid 17027485)
5. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. SM Huson PS Harper DA Compston, Brain 1988 111 1355 81 10.1093/brain/111.6.1355 3145091 (Pubitemid 19028458)
6. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. JM Friedman PH Birch, Am J Med Genet 1997 70 138 43 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U 9128932 (Pubitemid 27184570)
7. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force. KN North V Riccardi C Samango-Sprouse R Ferner B Moore E Legius N Ratner MB Denckla, Neurology 1997 48 1121 7 9109916
8. Neurological complications of neurofibromatosis type 1 in adulthood. A Créange J Zeller S Rostaing-Rigattieri P Brugières JD Degos J Revuz P Wolkenstein, Brain 1999 122 473 81 10094256 (Pubitemid 29110522)
9. NF1 gene and neurofibromatosis 1. SA Rasmussen JM Friedman, Am J Epidemiol 2000 151 33 40 10625171 (Pubitemid 30470392)
10. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. JM Friedman J Arbiser JA Epstein DH Gutmann SJ Huot AE Lin B McManus BR Korf, Genet Med 2002 4 105 11 10.1097/00125817-200205000- 00002 12180143 (Pubitemid 44698568)
11. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. DGR Evans ME Baser J McGaughran S Sharif E Howard A Moran, J Med Genet 2002 39 311 314 10.1136/jmg.39.5.311 12011145 (Pubitemid 34526349)
12. Mortality in Neurofibromatosis 1: An analysis using U.S. Deaths Certificates. SA Rasmussen Q Yang JM Friedman, Am J Hum Genet 2001 68 1110 1118 10.1086/320121 11283797 (Pubitemid 32424410)
13. Neurofibromatosis Type 1 and 2. K Yohay, Neurologist 2006 12 86 93 10.1097/01.nrl.0000195830.22432.a5 16534445
14. Geo Demo. Demografia in cifre. ISTAT. http://demo.istat.it
15. KJ Rothman S Greenland TL Lash, Modern Epidemiology Philadelphia: Lippincott-Williams-Wilkins 3 2008
16. NE Breslow NE Day, Statistical methods in cancer research Vol. II. The design and analysis of cohort studies Lyon: IARC Scientific Publications No. 82 1987
17. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. SA Sørensen JJ Mulvihill A Nielsen, N Engl J Med 1986 314 1010 5 3083258 (Pubitemid 16113061)
18. Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. GE Airewele AJ Sigurdson KJ Wiley BE Frieden LW Caldarera VM Riccardi RA Lewis MM Chintagumpala JL Ater SE Plon ML Bondy, Genet Epidemiol 2001 20 75 86 10.1002/1098-2272(200101)20:1<75::AID-GEPI7>3.0.CO;2-Z 11119298
19. Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity. A Zvulunov RR Weitz A Metzker, Clin Pediatr 1998 37 295 300 10.1177/000992289803700503 (Pubitemid 28223758)
20. Childhood neurofibromatosis: risk factors for malignant disease. M Schneider AC Obringer E Zackai AT Meadows, Cancer Genet Cytogenet 1986 21 347 54 10.1016/0165-4608(86)90216-5 3082511 (Pubitemid 16109616)
21. The role of steroid hormones in the NF1 phenotype: focus on pregnancy. TM Roth EM Petty KF Barald, Am J Med Genet 2008 146A 1624 33 10.1002/ajmg.a.32301 18481270 (Pubitemid 351792414)
22. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. L Walker D Thompson D Easton B Ponder M Ponder I Frayling D Baralle, Br J Cancer 2006 95 233 8 10.1038/sj.bjc.6603227 16786042 (Pubitemid 44050923)
23. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. JS Guillamo A Créange C Kalifam J Grill D Rodriguez F Doz S Barbarot M Zerah M Sanson S Bastuji-Garin P Wolkenstein NF Réseau France, Brain 2003 126 152 60 10.1093/brain/awg016 12477702 (Pubitemid 36068565)
24. A clinical study of type 1 neurofibromatosis in north west England. JM McGaughran DI Harris D Donnai D Teare R MacLeod R Westerbeek H Kingston M Super R Harris DG Evans, J Med Genet 1999 36 197 203 10204844 (Pubitemid 29110448)
25. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. ME Zoller B Rembeck A Oden M Samuelsson L Angervall, Cancer 1997 79 2125 35 10.1002/(SICI)1097-0142(19970601)79: 11<2125::AID-CNCR9>3.0.CO;2-N 9179058
26. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. DH Gutmann A Aylsworth JC Carey B Korf J Marks RE Pyeritz A Rubenstein D Viskochil, JAMA 1997 278 51 7 10.1001/jama.278.1.51 9207339 (Pubitemid 27274517)
27. NF1: a prevalent cause of tumorigenesis in human cancers? BR Seizinger, Nature Genet 1993 3 97 9 10.1038/ng0293-97 7848376 (Pubitemid 23079787)
28. Neurofibromatosis Type 1 and childhood cancer. I Matsui M Tanimura N Kobayashi T Sawada N Nagahara J Akatsuka, Cancer 1993 72 2746 53 10.1002/1097-0142(19931101)72:9<2746::AID-CNCR2820720936>3.0.CO;2-W 8402499
29. Neurofibromatosis type 1: a diagnostic mimicker at CT. BJ Fortman BS Kuszyk BA Urban EK Fishman, Radiographics 2001 21 601 12 11353109 (Pubitemid 33707077)
30. Spontaneous hemothorax in patients with von Recklinghausen's disease. T Miura Y Kawano M Chujo M Miyawaki H Mori K Kawahara, Jpn J Thorac Cardiovasc Surg 2005 53 649 52 10.1007/BF02665078 16408472 (Pubitemid 43058198)
31. Primary localised pleural neurofibroma: expanding the spectrum of spindle cell tumours of the pleura. G Langman S Rathinam L Papadaki, J Clin Pathol 2010 63 116 8 10.1136/jcp.2009.067264 20154031
32. Neurofibromatosis-associated lung disease: a case series and literature review. AC Zamora HR Collard PJ Wolters WR Webb TE King, Eur Respir J 2007 29 210 14 10.1183/09031936.06.00044006 16870664 (Pubitemid 46092016)
33. Respiratory manifestations in von Recklinghausen's disease. S Lovin D Veale, Pneumologia 2005 54 186 90 17069222
34. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? DR Stewart JD Cogan MR Kramer WT Miller Jr LE Christiansen MW Pauciulo LM Messiaen GS Tu WH Thompson RE Pyeritz JH Ryu WC Nichols M Kodama BO Meyrick DJ Ross, Chest 2007 132 798 808 10.1378/chest.06- 3017 17573495
35. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report. S Simeoni A Puccetti M Chilosi E Tinazzi D Prati R Corrocher C Lunardi, J Med Invest 2007 54 354 8 10.2152/jmi.54.354 17878687 (Pubitemid 350143751)
36. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1: a twelve-year follow-up of an epidemiological study in Goteborg, Sweden. M Zöller B Rembeck HO Akesson L Angervall, Acta Derm Venereol 1995 75 136 40 7604643
37. L Frova S Marchetti M Pace, Applying acs to causes of death statistics in Italy. Some clues on implementation, bridge coding and further steps Rome: Essay, n13, Istat 2004
38. Factors associated with reporting multiple causes of death. MM Wall J Huang J Oswald D McCullen, BMC Med Res Methodol 2005 5 4 10.1186/1471-2288-5-4 15655070
39. Using multiple cause-of-death data to investigate associations and causality between conditions listed on the death certificate. MD Redelings M Wise F Sorvillo, Am J Epidemiol 2007 166 104 108 10.1093/aje/kwm037 17426040 (Pubitemid 47234289)